Bruce Booth, Director at Kymera Therapeutics, Inc. (KYMR), sold 81,866 shares at $90.13 ($7.4M) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Scheduled sale ($7.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.13 | 10,052 | $906K | 12.3% |
| 2 | $90.13 | 71,814 | $6.5M | 87.7% |
| Total | $90.13 avg | 81,866 | $7.4M | 100% |
| Filing → |
| KYMR | SELL | 2026-06-30 | $56.5M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $34.8M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $44.0M | — | Filing → |